COSCIENS Biopharma Inc. Increase Decrease Through Exercise Of Warrants Equity
COSCIENS Biopharma Inc. (CSCIF) reported Increase Decrease Through Exercise Of Warrants Equity of $54.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2026-03-25
- COSCIENS Biopharma Inc. increase decrease through exercise of warrants equity for the quarter ending 2025-12-31 was $2.00K, a 89.47% decline year-over-year.
- COSCIENS Biopharma Inc. increase decrease through exercise of warrants equity for the quarter ending 2025-09-30 was $22.00K.
- COSCIENS Biopharma Inc. increase decrease through exercise of warrants equity for the quarter ending 2025-06-30 was $13.00K.
- COSCIENS Biopharma Inc. increase decrease through exercise of warrants equity for the quarter ending 2025-03-31 was $17.00K.
| Period end | Increase Decrease Through Exercise Of Warrants Equity 3 month | Increase Decrease Through Exercise Of Warrants Equity 6 month | Increase Decrease Through Exercise Of Warrants Equity 9 month | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $24.00K derived: sum of 2 quarters · filed 2026-03-25 | $37.00K derived: sum of 3 quarters · filed 2026-03-25 | $54.00K 20-F · filed 2026-03-25 |
| 2025-09-30 | $22.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $35.00K derived: sum of 2 quarters · filed 2025-11-12 | $52.00K 6-K · filed 2025-11-12 | $71.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-06-30 | $13.00K derived: 6-K 6 month − 6-K 3 month · filed 2025-08-14 | $30.00K 6-K · filed 2025-08-14 | $49.00K derived: sum of 3 quarters · filed 2026-03-25 | |
| 2025-03-31 | $17.00K 6-K · filed 2025-05-13 | $36.00K derived: sum of 2 quarters · filed 2026-03-25 | ||
| 2024-12-31 | $19.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $405.00K 20-F · filed 2026-03-25 | ||
| 2024-09-30 | $386.00K 6-K · filed 2025-11-12 | |||
| 2021-12-31 | $20.09M 20-F/A · filed 2024-07-17 | |||
| 2017-12-31 | $977.00K 20-F · filed 2018-03-28 | |||
| 2015-12-31 | $31.08M 20-F · filed 2018-03-28 |